FDA Classifies Non-Bug Infection Spotter Device
Published Date: 5/9/2025
Rule
Summary
The FDA is officially putting devices that detect and measure non-microbial signs of localized infections into a special safety category called Class II. This change helps make sure these devices are safe and work well, while also making it easier for patients to get new, helpful tools faster. Companies making these devices will now follow clear rules, which should speed up innovation without extra costs or delays.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Class II safety rules for infection tests
The FDA is classifying devices that detect and measure non-microbial analytes to aid in the detection and identification of localized human infections into Class II (special controls). This Class II classification, the agency says, will provide a reasonable assurance of safety and effectiveness for those devices.
Faster access, fewer regulatory burdens
The FDA says classifying these devices into Class II will reduce regulatory burdens and put clear special-control rules in place. The agency states this will enhance patients' access to innovative devices and should speed up innovation without extra costs or delays for companies making these devices.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in